AI

Allostery Investments Portfolio holdings

AUM $7.85M
This Quarter Return
-2.75%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$69.3M
AUM Growth
+$18.4M
Cap. Flow
+$22.4M
Cap. Flow %
32.32%
Top 10 Hldgs %
65.25%
Holding
55
New
16
Increased
11
Reduced
5
Closed
5

Top Buys

1
MRUS icon
Merus
MRUS
+$4.33M
2
ABVX
Abivax
ABVX
+$3.18M
3
BBIO icon
BridgeBio Pharma
BBIO
+$2.77M
4
SWTX
SpringWorks Therapeutics
SWTX
+$2.32M
5
BEAM icon
Beam Therapeutics
BEAM
+$1.81M

Top Sells

1
IONS icon
Ionis Pharmaceuticals
IONS
+$905K
2
MNMD icon
MindMed
MNMD
+$905K
3
DNTH icon
Dianthus Therapeutics
DNTH
+$545K
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$496K
5
JSPR icon
Jasper Therapeutics
JSPR
+$470K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PLRX icon
26
Pliant Therapeutics
PLRX
$97.6M
$596K 0.86%
+441,686
New +$596K
CNTX icon
27
Context Therapeutics
CNTX
$74.9M
$582K 0.84%
950,166
– –
PHGE icon
28
BiomX
PHGE
$12.6M
$523K 0.75%
940,629
+296,796
+46% +$165K
RLYB icon
29
Rallybio
RLYB
$25.1M
$492K 0.71%
752,235
-51,163
-6% -$33.5K
ELDN icon
30
Eledon Pharmaceuticals
ELDN
$145M
$339K 0.49%
100,000
– –
CLYM
31
Climb Bio, Inc. Common Stock
CLYM
$152M
$299K 0.43%
244,988
– –
ORKA
32
Oruka Therapeutics, Inc. Common Stock
ORKA
$577M
$205K 0.3%
20,000
– –
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$9.63B
$199K 0.29%
+600
New +$199K
ETNB icon
34
89bio
ETNB
$1.2B
$182K 0.26%
+25,000
New +$182K
PMN icon
35
ProMIS Neurosciences
PMN
$22.8M
$165K 0.24%
233,703
+38,592
+20% +$27.3K
LEGN icon
36
Legend Biotech
LEGN
$6.11B
$161K 0.23%
+4,750
New +$161K
VIR icon
37
Vir Biotechnology
VIR
$695M
$144K 0.21%
+22,202
New +$144K
WVE icon
38
Wave Life Sciences
WVE
$1.11B
$141K 0.2%
+17,500
New +$141K
ARQT icon
39
Arcutis Biotherapeutics
ARQT
$2.07B
$117K 0.17%
+7,500
New +$117K
EWTX icon
40
Edgewise Therapeutics
EWTX
$1.5B
$66K 0.1%
+3,000
New +$66K
LXEO icon
41
Lexeo Therapeutics
LXEO
$280M
$17.5K 0.03%
5,054
– –
ANAB icon
42
AnaptysBio
ANAB
$655M
– –
0
– –
APLS icon
43
Apellis Pharmaceuticals
APLS
$3.14B
– –
0
– –
CRNX icon
44
Crinetics Pharmaceuticals
CRNX
$3.2B
– –
-9,700
Closed -$496K
DNTH icon
45
Dianthus Therapeutics
DNTH
$1.48B
– –
-25,000
Closed -$545K
ELEV
46
DELISTED
Elevation Oncology
ELEV
– –
-432,206
Closed -$243K
JSPR icon
47
Jasper Therapeutics
JSPR
$39.5M
– –
-22,000
Closed -$470K
MNMD icon
48
MindMed
MNMD
$718M
– –
-130,000
Closed -$905K
NVAX icon
49
Novavax
NVAX
$1.3B
– –
0
– –
OLMA icon
50
Olema Pharmaceuticals
OLMA
$533M
– –
0
– –
1
2
3